Hederacoside C 3-methyl-5-methoxy-phenol 1-O-β-d-glucopyranosyl-(1 → 6)-β-d-glucopyranoside altered cellular oxygen consumption rate

altered cellular oxygen consumption rate and induced production of pAMPK

Especially

Niclosamide (BAY2353) is an orally bioavailable chlorinated salicylanilide

CC[N+](CC)=C1C=C2OC3=CC(=CC=C3C(C3=CC=C(C=C3S([O-])(=O)=O)S(=O)(=O)NCC3=CN(N=N3)[C@H]3CN([C@@H](C3)C(=O)N[C@@H](CC3C=CC(=CC=3)OC(=O)N3CCCC3)C(O)=O)S(=O)(=O)C3C=CC=CC=3)=C2C=C1)N(CC)CC

suppresses the progression of rheumatoid arthritis (RA) by inhibiting the activation of macrophages and osteoclastogenesis through downregulations of TNF-α

Hederacoside C 3-methyl-5-methoxy-phenol 1-O-β-d-glucopyranosyl-(1 → 6)-β-d-glucopyranoside altered cellular oxygen consumption rateHederacoside C is a principal active ingredient of Hedera helix leaf that can treat respiratory disorders, because of its expectorant, bronchodilator, antibacterial, and bronchospasmolytic effects. Product information CAS Number: 14216 03 6 Molecular Weight: 1221. 38 Formula: C59H96O26 Chemical Name: 6 ({[3,4 dihydroxy 6 (hydroxymethyl) 5 [(3,4,5 trihydroxy 6 methyloxan 2 yl)oxy]oxan 2 yl]oxy}methyl) 3,4,5 trihydroxyoxan 2 yl 10 ({4,5 dihydroxy 3